You can schedule an appointment at your local pharmacy, such as CVS, Walgreens, Safeway, or your primary care physician to get the RSV vaccine. The CDC said it is safe to get your RSV, flu and COVID ...

News Wrap: Pfizer says booster offers protection against omicron variant In our news wrap Wednesday, drug maker Pfizer says its double-dose vaccine — plus a booster — may offer significant ...

A new covid-19 variant called XEC may spread more easily than past variants, but current vaccines are still effective against ...

Covid XEC, a new variant of Coronavirus discovered in Germany in June, is spreading rapidly across Europe. This hybrid of omicron subvariants KS.1.1 and KP.3.3 may become the dominant strain by ...

After a considerable pause, the much dreaded COVID-19 scare is further resurfacing across countries in Europe and the United States with a newly discovered variant of the coronavirus called the XEC.

“XEC is definitely taking charge,” Dr Topol said. XEC, a sublineage of the omicron variant, was first reported in Berlin, Germany, in June and is now spreading “quite rapidly” across ...

Experts have said that the new variant, a sublineage of the omicron variant, has some new mutations that might help it spread this autumn, although vaccines should still help prevent severe cases.

The new and contagious XEC COVID-19 variant is spreading rapidly in several countries. Will it cause a surge in the U.S.?

A new COVID variant, XEC, has arrived just before fall. The new variant has sprouted from the omicron variant that was first identified in late 2021. It’s possible that XEC may “become the dominant ...

The CDC has not confirmed whether there are any unique symptoms from the XEC variant. USA TODAY has reached out to CDC officials for comment. The agency continues to outline the basic COVID-19 ...

Omicron variant KP.3.1.1, also known as deFLuQE, made up over half (52.7%) of COVID-19 cases between Sept. 1 and Sept. 14. However XEC and a variant known as MV.1 seem poised to become the next ...

It is derives from the Omicron variant. Last month, the new COVID vaccines from Moderna and Pfizer were approved for the 2024-2025 season. They were designed against KP.2, a predecessor of KP.3.1. ...